Skip to main content
Log in

Posture as a contributing factor to beta-blockade-induced hyperkalaemia

  • Letter To The Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Carlsson E, Fellenius E, Lundborg P, Svensson L (1978) Adrenoceptor blockers, plasma potassium, and exercise. Lancet 2: 424–425

    Google Scholar 

  2. Lim M, Linton RAF, Wolff CB, Band DM (1981) Propranolol, exercise and arterial plasma potassium. Lancet 2: 591

    Google Scholar 

  3. Rosa RM, Silva P, Young JB, Landsberg L, Brown R, Rowe JW, Epstein F (1980) Adrenergic modulation of extrarenal potassium disposal. N Eng J Med 302: 431–434

    Google Scholar 

  4. Rolf Smith S, Kendall MI, Ryder C, Laugher S (1984) Lack of influence of beta-adrenergic blockade on serum potassium during an infusion of potassium. Eur J Clin Pharmacol 26: 425–427

    Google Scholar 

  5. Radó JP, Simatupang T, Boer P, Dorhout Mees EJ (1979) Increase of serum potassium in the upright posture in selective hypoaldosteronism. Horm Metab Res 11: 47–51

    Google Scholar 

  6. Radó JP, Hartai A, Kárpáti E, Gercsák Gy, Molnár Zs (1981) Influence of posture on serum potassium changes during standard glucose tolerance test. Res Comm Chem Path Pharm 32: 179–180

    Google Scholar 

  7. Radó JP (1982) A role for the upright posture in the development of glucose-induced hyperkalemia: prevention by a mineralocorticoid. Horm Metab Res 14: 551

    Google Scholar 

  8. Radó JP (1983) Glucose-induced hyperkalemia during captopril treatment. Arch Int Med 143: 389

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Radó, J.P. Posture as a contributing factor to beta-blockade-induced hyperkalaemia. Eur J Clin Pharmacol 28, 359–360 (1985). https://doi.org/10.1007/BF00543339

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00543339

Key words

Navigation